252 related articles for article (PubMed ID: 35528149)
21. The Role of PIEZO1 in Urinary Bladder Function and Dysfunction in a Rodent Model of Cyclophosphamide-Induced Cystitis.
Beča KIK; Girard BM; Heppner TJ; Hennig GW; Herrera GM; Nelson MT; Vizzard MA
Front Pain Res (Lausanne); 2021; 2():748385. PubMed ID: 35295484
[TBL] [Abstract][Full Text] [Related]
22. Expression and Function of Chemokines CXCL9-11 in Micturition Pathways in Cyclophosphamide (CYP)-Induced Cystitis and Somatic Sensitivity in Mice.
Guo M; Chang P; Hauke E; Girard BM; Tooke K; Ojala J; Malley SM; Hsiang H; Vizzard MA
Front Syst Neurosci; 2018; 12():9. PubMed ID: 29681802
[TBL] [Abstract][Full Text] [Related]
23. Role of p75NTR in female rat urinary bladder with cyclophosphamide-induced cystitis.
Klinger MB; Vizzard MA
Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1778-89. PubMed ID: 18842820
[TBL] [Abstract][Full Text] [Related]
24. The effects of a galectin-3 inhibitor on bladder pain syndrome in mice with cyclophosphamide-induced cystitis.
Xiao H; Wang T; Gao B; Liu J; Li S; Ma J
Neurourol Urodyn; 2024 Mar; 43(3):754-766. PubMed ID: 38356381
[TBL] [Abstract][Full Text] [Related]
25. Deletion or pharmacological blockade of TLR4 confers protection against cyclophosphamide-induced mouse cystitis.
de Oliveira MG; Mónica FZ; Calmasini FB; Alexandre EC; Tavares EBG; Soares AG; Costa SKP; Antunes E
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F460-F468. PubMed ID: 29717937
[TBL] [Abstract][Full Text] [Related]
26. Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction.
Vizzard MA
Exp Neurol; 2000 Jan; 161(1):273-84. PubMed ID: 10683293
[TBL] [Abstract][Full Text] [Related]
27. Expression of fractalkine and fractalkine receptor in urinary bladder after cyclophosphamide (CYP)-induced cystitis.
Yuridullah R; Corrow KA; Malley SE; Vizzard MA
Auton Neurosci; 2006 Jun; 126-127():380-9. PubMed ID: 16651033
[TBL] [Abstract][Full Text] [Related]
28.
Li W; Yang F; Zhan H; Liu B; Cai J; Luo Y; Zhou X
Evid Based Complement Alternat Med; 2020; 2020():9026901. PubMed ID: 33133219
[TBL] [Abstract][Full Text] [Related]
29. Periostin Attenuates Cyclophosphamide-induced Bladder Injury by Promoting Urothelial Stem Cell Proliferation and Macrophage Polarization.
Chen Z; Liu L; Chen Y; Liu M; Peng Xiang A; Deng C; Jiang MH
Stem Cells Transl Med; 2022 Jun; 11(6):659-673. PubMed ID: 35648087
[TBL] [Abstract][Full Text] [Related]
30. Expression and function of CXCL12/CXCR4 in rat urinary bladder with cyclophosphamide-induced cystitis.
Arms L; Girard BM; Vizzard MA
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F589-600. PubMed ID: 20032115
[TBL] [Abstract][Full Text] [Related]
31. Expression of cyclooxygenase-2 in urinary bladder in rats with cyclophosphamide-induced cystitis.
Klinger MB; Dattilio A; Vizzard MA
Am J Physiol Regul Integr Comp Physiol; 2007 Aug; 293(2):R677-85. PubMed ID: 17537839
[TBL] [Abstract][Full Text] [Related]
32. Expression and response of acid-sensing ion channels in urinary bladder to cyclophosphamide-induced cystitis.
Corrow K; Girard BM; Vizzard MA
Am J Physiol Renal Physiol; 2010 May; 298(5):F1130-9. PubMed ID: 20164155
[TBL] [Abstract][Full Text] [Related]
33. Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study.
Ostardo E; Impellizzeri D; Cervigni M; Porru D; Sommariva M; Cordaro M; Siracusa R; Fusco R; Gugliandolo E; Crupi R; Schievano C; Inferrera A; Di Paola R; Cuzzocrea S;
Pharmacol Res; 2018 Aug; 134():16-30. PubMed ID: 29800607
[TBL] [Abstract][Full Text] [Related]
34. Decrease of urinary nerve growth factor but not brain-derived neurotrophic factor in patients with interstitial cystitis/bladder pain syndrome treated with hyaluronic acid.
Jiang YH; Liu HT; Kuo HC
PLoS One; 2014; 9(3):e91609. PubMed ID: 24614892
[TBL] [Abstract][Full Text] [Related]
35. Rho kinase inhibition ameliorates cyclophosphamide-induced cystitis in rats.
Wróbel A; Doboszewska U; Rechberger E; Rojek K; Serefko A; Poleszak E; Skalicka-Woźniak K; Dudka J; Wlaź P
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):613-619. PubMed ID: 28220212
[TBL] [Abstract][Full Text] [Related]
36. Exaggerated expression of inflammatory mediators in vasoactive intestinal polypeptide knockout (VIP-/-) mice with cyclophosphamide (CYP)-induced cystitis.
Girard BM; Malley SE; Braas KM; Waschek JA; May V; Vizzard MA
J Mol Neurosci; 2008 Nov; 36(1-3):188-99. PubMed ID: 18483878
[TBL] [Abstract][Full Text] [Related]
37. Role of c-Jun N-terminal kinase (JNK) activation in micturition reflexes in cyclophosphamide (CYP)-induced cystitis in female rats.
Dugan C; Malley S; Arms L; May V; Vizzard MA
J Mol Neurosci; 2014 Nov; 54(3):360-9. PubMed ID: 24763745
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of U-II/UT signaling ameliorates cystitis-associated bladder hyperactivity by targeting the RhoA/Rho-kinase pathway.
Liu Q; Lu QD; Sun BS; Zhao J; He F; Zhu JZ
Kaohsiung J Med Sci; 2022 Sep; 38(9):879-888. PubMed ID: 35766129
[TBL] [Abstract][Full Text] [Related]
39. Intravesical administration of blebbistatin prevents cyclophosphamide-induced toxicity of the urinary bladder in female Wistar rats.
Wróbel A; Serefko A; Bańczerowska-Górska M; Szopa A; Dudka J; Poleszak E
Neurourol Urodyn; 2019 Apr; 38(4):1044-1052. PubMed ID: 30869827
[TBL] [Abstract][Full Text] [Related]
40. A novel role for follistatin in hypersensitivity following cystitis.
Shaffer AD; Feng B; La JH; Joyce SC; Gebhart GF
Neurourol Urodyn; 2017 Feb; 36(2):286-292. PubMed ID: 26713850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
